Latest Safety News

MC Mining has officially begun open pit mining at its flagship Makhado hard coking coal project in South Africa, advancing steadily towards full production by year-end 2025.

HITIQ Limited has successfully closed its shortfall offer, raising a total of $2.16 million through a combination of a rights issue and placement, while continuing discussions to secure additional funding.

Truscott Mining Corporation has confirmed a $577,890 capital raise through a rights issue, explaining its exploration expenditure and operational status amid a drilling hiatus since late 2022. The company underscores its commitment to long-term project development and compliance with ASX listing requirements.

Nyrada Inc has responded to ASX inquiries confirming the timely and compliant disclosure of positive safety data from its Phase I clinical trial of Xolatryp. The company detailed the timeline of its awareness and release of information, affirming adherence to continuous disclosure rules.

Argenica Therapeutics has received detailed FDA feedback outlining specific data requirements to lift the clinical hold on its ARG-007 stroke trial in the US, setting a clear path forward for its neuroprotective drug.

Noble Helium has launched a rigorously vetted five-hole drilling campaign targeting a 225.5 BCF helium resource in Tanzania’s North Rukwa Project, aiming for near-term cash flow with reduced costs and enhanced geological insight.

Orora Limited reported solid FY25 financial results driven by strong performance in its Cans business and the Saverglass acquisition, alongside key capacity expansions and glass network optimizations. The company’s robust balance sheet supports ongoing shareholder returns and a positive outlook for FY26.

Ventia Services Group has upgraded its FY25 profit guidance following a strong first half marked by record contract wins and an expanded share buyback program.

Orora Limited reported a 24.4% increase in FY25 revenue to A$2.09 billion, marking the completion of its strategic portfolio reshaping with the sale of its North American packaging business. The company advances sustainability targets while maintaining steady dividends and a share buyback program.

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.

New Zealand Coastal Seafoods Limited has completed a major vessel upgrade, attracted international investment, and is preparing to resume ASX trading after strategic corporate changes.

Evolution Mining has delivered a landmark FY25 with record profits and cash flow, tripling its final dividend, while setting a stable production and cost outlook for FY26 amid ongoing project developments and sustainability commitments.